Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 60 (RPL7AP60)

Target: RPL7AP60
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L7a pseudogene 60 (RPL7AP60) is a processed pseudogene related to the gene encoding ribosomal protein L7a (RPL7A). As a pseudogene, RPL7AP60 does not produce a functional protein and is not considered a therapeutic or diagnostic target. Multiple processed pseudogenes such as RPL7AP60 are common for ribosomal protein genes and usually lack biological functions. There are no known disease associations, drug interactions, or established biomarker roles for this pseudogene.

Other names: RPL7A_25_1279RPL7AP60

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 60 (RPL7AP60).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 60 (RPL7AP60).

Explore the full profile